Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- 2 November 2016
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 66 (3), 545-551
- https://doi.org/10.1016/j.jhep.2016.10.029
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinomaJournal of Hepatology, 2012
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaEuropean Journal Of Cancer, 2012
- Standardizing immunophenotyping for the Human Immunology ProjectNature Reviews Immunology, 2012
- Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinomaHepatology, 2011
- Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell ResponseGastroenterology, 2010
- Strong CD8+ T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinomaThe Esophagus, 2009
- Radiofrequency Ablation Combined with KS-IL2 Immunocytokine (EMD 273066) Results in an Enhanced Antitumor Effect against Murine Colon AdenocarcinomaClinical Cancer Research, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Spontaneous Tumor-Specific Humoral and Cellular Immune Responses to NY-ESO-1 in Hepatocellular CarcinomaClinical Cancer Research, 2004
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002